Insulin-like growth factor-binding proteins (IGFBP)-4, -5, and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3783-3792

  Tennant, Marie K ^a,b   Thrasher, J Brantley ^c   Twomey, Patrick A ^c   Birnbaum, Roger S ^a,b   Plymate, Stephen R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN;

ARTICLE; CELL INTERACTION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MITOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

AGED; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; KERATINS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 0029836795     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3783     Document Type: Article

References (52)

1. Rosenfeld RG, Lamson GL, Hung P, et al. 1990 Insulin-like growth factor binding proteins. Recent Prog Horm Res. 46:99-163.
2. Shimasaki S, Ling N. 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, -6). Prog Growth Factor Res. 3:243-266.
3. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3-34.
4. Clemmons D. 1992 IGF binding proteins: regulation of cellular actions. Growth Regul. 2:80-87.
5. Andress D, Birnbaum R. 1992 Human osteoblast-derived insulin-like growth factor binding protein (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem. 267:22467-22472.
6. Oh Y, Muller HL, Lamson G, Rosenfeld RG. 1993 Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem. 268:14964-14971.
7. Rechler MM. 1993 Insulin-like growth factor binding proteins. In: McCormick DB, ed. Vitamins and hormones. San Diego: Academic Press; 47:1-114.
8. Clemmons DR, Jones JI, Busby WH, Wright G. 1993 Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann NY Acad Sci. 692:10-21.
9. Conover CA. 1992 Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology. 130:3191-3199.
10. Jones JI, Gockerman A, Busby WH, Camacho-Hubner C, Clemmons DR. 1993 Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol. 121:679-987.
11. Fowlkes J, Freemark M. 1992 Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. Endocrinology. 131:2071-2076.
12. Lassarre C, Binoux M. 1994 Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology 134:1254-1262.
13. Blat C, Villaudy J, Binoux M. 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest. 93:2286-2290.
14. Clemmons DR, Underwood LE, Chatelain PG, Van-Wyk JJ. 1983 Liberation of immunoreactive somatomedian-C from its binding proteins by proteolytic enzymes and heparin. J Clin Endocrinol Metab. 56:384-389.
15. Oh Y, Muller HL, Ng L, Rosenfeld RG. 1995 Transforming growth factor-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor binding protein-3 action. J Biol Chem. 270:13589-13592.
16. Buckbinder L, Talbott R, Velasco-Miguel S, et al. 1995 Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature. 377:646-649.
17. Barni T, Vannelli B, Sadri R, et al. 1994 Insulin-like growth factor-I and its binding protein IGFBP-4 in human prostaric hyperplastic tissue: gene expression and its cellular localization. J Clin Endocrinol Metab. 78:778-783.
18. Boudon C, Rodier G, Lechevallier E, Mottet N, Barenton N, Sultan Ch. 1996 Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture. J Clin Endocrinol Metab. 81:612-617.
19. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. 1991 Insulin-like growth factors (IGFs), IGF receptors, and IGF binding proteins in primary cultures of epithelial cells. J Clin Endocrinol Metab. 73:401-407.
20. Cohen P, Peehl DM, Baker B, Liu F, Hintz RL, Rosenfeld RG. 1994 Insulin-like growth factor axis abnormalities in prostaric stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab. 79:1410-1415.
21. Fiorelli G, de Bellis A, Longo A, et al. 1991 Growth factors in the human prostate. J Steroid Biochem Mol Biol. 40:199-205.
22. Fiorelli G, de Bellis A, Longo A, et al. 1991 Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab. 72:740-746.
23. Baserga R. 1995 The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55:249-252.
24. Cohen P, Peehl DM, Stamey T, Wilson K, Clemmons DR, Rosenfeld RG. 1993 Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab. 76:1031-1035.
25. Kanety H, Madjar Y, Dagan Y, et al. 1993 Serum insulin-like growth factor binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate specific antigen. J Clin Endocrinol Metab. 77:229-233.
26. Birnbaum RS, Ware JL, Plymate SR. 1994 Insulin-like growth factor binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts. J Endocrinol. 141:533-540.
27. Figueroa JA, Lee AV, Jackson JG, Yee D. 1995 Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop. J Clin Endocrinol Metab. 80:3476-3482.
28. Angelloz-Nicound P, Binoux M. 1995 Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136:5485-5492.
29. 28a.Plymate SR, Tennant M, Birnbaum RS, Thrasher JB, Chatta G, Ware JL. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen. J Clin Endocrinol Metab. 81:3709-3716.
30. 3. Prostate. 26:72-79.
31. Kaughn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. 1979 Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 17:16-20.
32. Petein M, Michel P, Velthoven RV, et al. 1991 Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. Am J Clin Pathol. 96:628-634.
33. Horoszewicz JS, Leong SS, Kawinski E, et al. 1983 LNCaP model of human prostatic carcinoma. Cancer Res. 43:1809-1818.
34. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. 1978 Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer. 21:274-281.
35. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS, Plymate SR. 1996 Insulin-like growth factor binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. J Clin Endocrinol Metab. 81:411-420.
36. Mostofi FK, Davis CJ Jr, Sesterhenn IA. 1993 Histopathology of prostate cancer. In: Lepor H, Lawson R, eds. Prostate diseases. Philadelphia: Saunders; 229-256.
37. McNeal JE. 1988 Significance of duct-acinar dysplasia in prostate carcinogenesis. Prostate. 13:91-102.
38. Mostofi FK, Davis CJ Jr. 1990 Male reproductive system. In: Kissane M, ed. Anderson's pathology. St Louis: Mosby; 907-915.
39. Peehl DM. 1995 Basic biological studies of prostate disease: translation to clinical application. In: Staney TA, ed. Monographs in urology. Monteverde, FL; Medical Directions: 16:19-37.
40. Camacho-Hubner C, McCusker RH, Clemmons DR. 1991 Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro. J Cell Physiol. 148:281-289.
41. Perkel VS, Mohan S, Baylink DJ, Linkart TA. 1990 An inhibitory insulin-like growth factor binding protein (In-IGFBP) from human prostatic cell conditioned medium reveal N-terminal sequence identity with bone derived In-IGFBP. J Clin Endocrinol Metab. 71:553-535.
42. Conover CA, Kiefer MC, Zapf J. 1993 Posttranslational regulation of insulin-like growth factor binding-4 in normal and transformed human fibroblasts. J Clin Invest. 91:1129-1137.
43. Culouscou JM, Shoyab M. 1991 Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein. Cancer Res. 51:2813-3819.
44. Andress DL. 1995 Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells. J Biol Chem. 270:28289-28296.
45. Delhanty PJD, Han VKM. An RGD to RGE mutation in the putative membrane binding domain of insulin-like growth factor binding protein-2 inhibits its potentiation of IGF-II induced thymidine uptake by SPC cells. Proc of the 75th Annual Meet of The Endocrine Soc. 1993;56.
46. Bourner MJ, Busby WA, Seigel NR, Krivi GG, McCusker RH, Clemmons DR. 1992 Cloning and sequence determination of insulin-like growth factor binding protein-2 (IGFBP): comparison with IGFBP-1. J Cell Biochem. 48:215-226.
47. Jones JI, Gockerman A, Busby WH, Wright G, Clemmons DR. 1993 Insulin-like growth factor binding protein-1 stimulates cell migration and binds to the α5βN1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA. 90:10553-10557.
48. Kaicer E, Blat C, Imbenotte J, et al. 1993 IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. Growth Regul. 3:180-189.
49. Cohen P, Peehl DM, Graves HC, Rosenfeld RG. 1994 Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol. 142:407-415.
50. Kato M, Ishizaki A, Hellman U, et al. 1995 A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor- and insulin-like growth factor binding-6, in a calcium- and cell density-dependent manner. J Biol Chem. 270:12373-12379.
51. Bach LA, Hsieh S, Brown AL, Rechler MM. 1994 Recombinant human insulin-like growth factor (IGF) binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. Endocrinology. 135:2168-2176.
52. Martin JL, Willetts KE, Baxter RC. 1990 Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. J Biol Chem. 265:4124-4130.